AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 51 filers reported holding AMBRX BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,252,167 | -44.3% | 1,761,058 | -20.3% | 0.00% | -33.3% |
| Q2 2023 | $36,386,772 | -7.7% | 2,210,618 | -50.0% | 0.00% | +50.0% |
| Q1 2023 | $39,437,426 | +544.4% | 4,421,236 | +64.0% | 0.00% | +100.0% |
| Q4 2022 | $6,120,066 | +57.9% | 2,696,064 | -24.9% | 0.00% | – |
| Q3 2022 | $3,876,000 | -62.1% | 3,588,467 | -7.0% | 0.00% | -100.0% |
| Q2 2022 | $10,223,000 | -35.1% | 3,857,679 | +0.8% | 0.00% | 0.0% |
| Q1 2022 | $15,760,000 | -54.7% | 3,825,359 | -0.8% | 0.00% | -66.7% |
| Q4 2021 | $34,811,000 | -30.8% | 3,855,025 | -0.0% | 0.00% | -25.0% |
| Q3 2021 | $50,300,000 | -26.8% | 3,856,225 | +2.4% | 0.00% | -20.0% |
| Q2 2021 | $68,727,000 | – | 3,766,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 16,688,636 | $191,919,314 | 67.54% |
| Cormorant Asset Management, LP | 9,923,689 | $114,122,424 | 6.66% |
| COMMODORE CAPITAL LP | 3,518,556 | $40,463,394 | 4.73% |
| Ally Bridge Group (NY) LLC | 281,089 | $3,232,524 | 3.79% |
| Paradigm Biocapital Advisors LP | 3,488,596 | $40,118,854 | 2.72% |
| VR Adviser, LLC | 2,070,000 | $23,805,000 | 2.51% |
| Ghost Tree Capital, LLC | 525,000 | $6,037,500 | 1.99% |
| HighVista Strategies LLC | 193,701 | $2,227,562 | 1.03% |
| Ikarian Capital, LLC | 4,932 | $5,671,800 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 34,000 | $391,000 | 0.51% |